Taylor & Francis
+3
1744-8328
Monthly
2.9
1473-7140
2001
4402080520500
YES
United Kingdom
English
YES
GOOGLE SCHOLAR
enquiries@taylorandfrancis.com
Expert Review of Anticancer Therapy [ISSN 1473-7140]; [e-ISSN 1744-8328] is a MEDLINE-indexed, international subscription-based journal publishing comprehensive peer-reviewed content on the major issues in clinical oncology. Coverage in the journal is focused on, but not limited to, the following key areas: Anticancer agents Novel therapies in development Cancer management Biomarkers Diagnostics Clinical trials Treatment guidelines The journal welcomes clinically focused original research, reviews, editorials and drug profile articles. Please note that the journal does not accept case reports or case series and does not accept papers focused on pre-clinical work and/or animal studies. Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.